HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Smooth muscle cell outgrowth from coronary atherectomy specimens in vitro is associated with less time to restenosis and expression of a key Transcription factor KLF5/BTEB2.

Abstract
Atherectomy specimens offer an opportunity to study the biology of coronary artery lesions. We cultured smooth muscle cells (SMCs) from specimens obtained from 24 patients with coronary restenosis after angioplasty to study the relationship between activity of SMCs (in vitro outgrowth) and the time course of restenosis. We also examined expression of a Kruppel-like zinc-finger transcription factor 5 (KLF; also known as BTEB2 and IKLF), which is markedly induced in activated SMCs, in the same specimens. SMC outgrowth was observed in 9 of 24 specimens (37.5%). Restenosis occurred sooner (p < 0.01) in patients whose specimens showed outgrowth compared to those whose specimens showed no outgrowth. Immunostaining for KLF5 was more common in specimens with outgrowth (89 vs. 20%, p < 0.01). These data suggest that the number of activated SMCs in lesions may determine in vitro outgrowth and also affect the time to restenosis.
AuthorsHironosuke Sakamoto, Tetsuo Sakamaki, Tsugiyasu Kanda, Yo-ichi Hoshino, Yoshie Sawada, Mahito Sato, Hiroko Sato, Yuko Oyama, Akihiko Nakano, Shin-ichi Takase, Akira Hasegawa, Ryozo Nagai, Masahiko Kurabayashi
JournalCardiology (Cardiology) Vol. 100 Issue 2 Pg. 80-5 ( 2003) ISSN: 0008-6312 [Print] Switzerland
PMID14557694 (Publication Type: Comparative Study, Journal Article)
CopyrightCopyright 2003 S. Karger AG, Basel
Chemical References
  • KLF5 protein, human
  • Kruppel-Like Transcription Factors
  • Trans-Activators
Topics
  • Aged
  • Atherectomy, Coronary
  • Cells, Cultured
  • Coronary Restenosis (epidemiology, metabolism, surgery)
  • Coronary Vessels (cytology, metabolism, pathology)
  • Female
  • Follow-Up Studies
  • Humans
  • Kruppel-Like Transcription Factors
  • Male
  • Middle Aged
  • Myocytes, Smooth Muscle (metabolism, pathology)
  • Risk Factors
  • Statistics as Topic
  • Time Factors
  • Trans-Activators (biosynthesis)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: